All In Biotech

Free tool

FAERS Monitor: Oriahnn (Copackaged)

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213388 or its brand name (Oriahnn (Copackaged), Elagolix Sodium,Estradiol,Norethindrone Acetate, Elagolix Sodium). Reports on generic versions are filed under their own applications.

Reports

600

Serious

192

32% of reports

Hospitalization

46

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • alopecia71
  • heavy menstrual bleeding66
  • headache56
  • nausea51
  • abnormal uterine bleeding34
  • hot flush32
  • uterine leiomyoma32
  • haemorrhage29
  • surgery29
  • fatigue28
  • intermenstrual bleeding27
  • hysterectomy25
  • vaginal haemorrhage25
  • vomiting24
  • depression21

Reports by year received

View as table
YearReports
202078
2021262
2022199
202344
202413
20254

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,559 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
abnormal uterine bleedingSignal34470.8338.915,270
heavy menstrual bleedingSignal66259.0206.116,593
intermenstrual bleedingSignal27170.2117.64,354
uterine leiomyomaSignal32154.1109.94,698
hysterectomySignal25101.569.12,382
vaginal haemorrhageSignal2520.213.8438
surgerySignal2917.312.2432
hot flushSignal3214.910.6402
alopeciaSignal7112.710.2759
haemorrhageSignal299.76.8219
depressionSignal213.22.131
headacheSignal563.12.482
nauseaSignal512.31.736
vomiting241.81.28
fatigue281.30.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.